as on January 19, 2026 at 4:01 pm IST
Day's Low
Day's High
2.44%
Downside
1.28%
Upside
52 Week's Low
52 Week's High
63.18%
Downside
39.82%
Upside
as on January 19, 2026 at 4:01 pm IST
Market Cap
₹843.10 Cr
Return on Equity (ROE)
13.36
PE Ratio (TTM)
36.55
Return on capital employed (ROCE)
17.49
Industry PE ratio
41.53
Beta (LTM)
0.67
P/B Ratio
2.4
Dividend Yield
0.47
PEG Ratio
-13.74
Quarterly Earnings Growth YOY
37.2
EPS (TTM)
22.11
Sector
Pharmaceuticals
Book Value
185.64
Technical Analysis
Bearish
View Technical Analysis
as on January 19, 2026 at 4:01 pm IST
Titan Biotech in the last 5 years
Lowest (3.20x)
June 30, 2020
Today (36.55x)
January 16, 2026
Industry (41.53x)
January 16, 2026
Highest (48.65x)
October 15, 2025
Today’s Price to Earnings Ratio: 36.55x
Compare market cap, revenue, PE, and other key metrics of Titan Biotech with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 843.10 | 100.38% | 0.51 | 18 | 156 | |
| NA | 69.66 | 15.48% | 0.00 | 7 | 285 | |
| NA | 181.95 | 9.61% | 0.00 | 4 | 473 | |
| NA | 1,773.02 | 21.32% | 0.53 | 60 | 759 | |
| BUY | 3,673.84 | 42.46% | 0.56 | 95 | 921 |
Get share price movements and forecasts by analysts on Titan Biotech.
Source: S&P Global Market Intelligence
Search interest for Titan Biotech Ltd Stock has decreased by -10% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Titan Biotech.
Titan Biotech Ltd’s net profit jumped 15.82% since last year same period to ₹7.76Cr in the Q2 2025-2026. On a quarterly growth basis, Titan Biotech Ltd has generated 13.12% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2025, Titan Biotech Ltd has declared dividend of ₹2.00 per share on 30 May 2025 - translating a dividend yield of 0.19%.
Read More about DividendsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 3 Years
![]()
In the last 3 years, Titan Biotech has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Profit Spike
![]()
Netprofit is up for the last 3 quarters, 4.05 Cr → 7.76 Cr (in ₹), with an average increase of 26.3% per quarter
Best in 1 Year
![]()
In the last 1 year, Titan Biotech has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Price Rise
![]()
In the last 6 months, Titan Biotech stock has moved up by 123.8%
Revenue Rich
![]()
Revenue is up for the last 3 quarters, 36.55 Cr → 55.68 Cr (in ₹), with an average increase of 18.9% per quarter
Retail Holding Unchanged
![]()
Retail Investor holdings remained unchanged at 44.19% of holdings in Dec 2025 quarter
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 55.78% of holdings in Dec 2025 quarter
| Organisation | Titan Biotech Ltd |
| Headquarters | New Delhi |
| Industry | Pharmaceuticals |
| CEO | Rohit Jain |
| E-voting on shares | Click here to vote |
Titan Biotech share price today stands at ₹1014.9 as on at the close of the market. Titan Biotech share today touched a day high of ₹1027.85 and a low of ₹990.1.
Titan Biotech touched a 52 week high of ₹1419 and a 52 week low of ₹373.65. Titan Biotech share price today i.e. is closed at ₹1014.9, which is -28.48% down from its 52 week high and 171.62% up from its 52 week low.
Titan Biotech market capitalisation is ₹843.10 Cr as on .
To buy Titan Biotech shares, you need to follow these steps:
Titan Biotech trading volume is 5,029.00 as on . This means that 5,029.00 shares of Titan Biotech were bought and sold on the stock market during today's trading session.